While invasive ductal carcinoma (IDC) is the most common form of invasive breast cancer, responsible for 80% of all cases in the U.S., it is not the most aggressive. Triple-negative breast cancers tend to grow
There were no significant differences in T stage, nodal status, family history, final margin, ER/PR/HER-2 status or triple negative tumors (all p-values >0.05). From the immuno-histochemical analysis, expression of p53, COX-2, and Bcl-2 did not differ significantly (all p-values >0.05)...
Published:2023Journal:JOURNAL OF ETHNOPHARMACOLOGYApplication:nullIF:5.4Species:nullPMID:37778516 Transcriptionally regulated miR-26a-5p may act as BRCAness in Triple-Negative Breast Cancer Published:2023Journal:BREAST CANCER RESEARCHApplication:nullIF:7.4Species:nullPMID:37365643 上一页1下一页 相关产品>...
[3]FDA Approves KEYTRUDA® (pembrolizumab) for Treatment of Patients With High-Risk Early-Stage Triple-Negative Breast Cancer in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Single Agent as Adjuvant Treatment After Surgery - Merck.com [4]FRONTiER: A feasibility trial of...
寡核苷酸探针稀释液 规格/价格 1ml/60 试剂盒内容 35%去离子甲酰胺;gelatin;Ficoll;SDS;Dextran sulfate;DNA 等 使用说明 按照一定比例稀释寡核苷酸探针 保存条件 4℃保存,一年有效。 注意事项 1、注意低温保存,避免污染 文献引用格式 寡核苷酸探针稀释液 (Boster Biological Technology, Wuhan, China. Catalog#AR00...